Metastatic cutaneous Crohn's: treat skin or bowel first

What is known

• There is no gold-standard therapy and no trials for metastatic [Crohn's disease](https://crohnsology.org (patient sites: crohnz.org)/); treatment rests on anecdotal case reports. ^1–3
• Metastatic cutaneous Crohn's more commonly parallels gastrointestinal disease activity, though it can also occur independently of bowel symptoms. ^2,4
• Systemic corticosteroids, immunosuppressants (azathioprine, methotrexate) and anti-TNF biologics have shown mixed but sometimes good responses for the skin lesions. ^1,3,5
• In one case, repetitive infliximab improved both cutaneous and fistulizing bowel disease, with methotrexate added to sustain remission. ⁶

What is unknown / caveats

• Metastatic skin disease can parallel gut activity in some cases yet arise independently (even years after proctocolectomy) in others
• One review recommends surgical debridement over medical management for perineal disease, while other reports favor systemic/biologic therapy
• Evidence is limited to case reports and small reviews; no comparative or randomized data
• No excerpt directly addresses prioritizing skin versus bowel when both are active
• Whether metastatic skin lesions will respond in parallel with bowel control is unpredictable, as some cases persist or progress despite biologic-controlled or surgically resected gut disease.

References

1. Chuah JH, Kim DS, Allen C, Hollis L. Metastatic Crohn's disease of the ear. Int J Otolaryngol. 2009. PMID: 20111588.

2. Guest GD, Fink RL. Metastatic Crohn's disease: case report of an unusual variant and review of the literature. Dis Colon Rectum. 2000;43(12):1764-6. PMID: 11156465.

3. Aberumand B, Howard J, Howard J. Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder. Biomed Res Int. 2017. PMID: 28127561.

4. Lester LU, Rapini RP. Dermatologic manifestations of colonic disorders. Curr Opin Gastroenterol. 2009;25(1):66-73. PMID: 19119511.

5. Pereira AS, Coutinho I. A Challenging Case of Metastatic Crohn's Disease Without Gastrointestinal Manifestations. Cureus. 2023. PMID: 37872941.

6. Konrad A, Seibold F. Response of cutaneous Crohn's disease to infliximab and methotrexate. Dig Liver Dis. 2003;35(5):351-6. PMID: 12846408.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.